Ethyl 2-methylimidazo[1,2-a]pyridine-3-carboxylate, 95.0%, 5g

5-Oxo-5-pyrrolidin-1-yl-pentanoic acid, 95+%, 1g

2-((2R,3R)-4-(Anthracen-9-yl)-3-(tert-butyl)-2,3-dihydrobenzo[d][1,3]oxaphosphol-2-yl)pyridine, 97%, 1g

2-carboethoxy-2'-thiomorpholinomethyl benzophenone, 97.0%, 1g

3-bromo-4-chloro-1H-pyrazolo[3,4-b]pyridine, 95%, 250mg

Iron foil 99.5% 1.5 x 100 x 100 mm 1 pc

L-4-Fluorophenylglycine, 97.0%, 25g

1,8-diazabicyclo[5.4.0]undec-7-ene (DBU), min. 98%, for synthesis, 250 ml, glass packaging

2-amino-4-(1H-tetrazol-5-yl)benzoic acid, 95.0%, 10g

6-(Trifluoromethyl)-1H-benzo[d]imidazol-2-amine, 95.0%, 250mg

5-Aminomethylthiazole hydrochloride, 95.0%, 5g

3-(3-bromophenyl)-5-methyl-4,5-dihydro-1,2-oxazole-5-carboxylic acid, 95.0%, 1g

6-Bromo-3-chloropyrazin-2(1H)-one, 98%, 1g